2022
A response to: Letter to the editor regarding "Network meta-analysis of food and drug administration-approved treatment options for adults with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder".
Wingerchuk, D.M. and Zhang, I. and Kielhorn, A. and Royston, M. and Levy, M. and Fujihara, K. and Nakashima, I. and Tanvir, I. and Paul, F. and Pittock, S.J.
Neurology and Therapy
2 July 2022
Therapy switches in fingolimod-treated patients with multiple sclerosis: long-term experience from the German MS Registry.
Frahm, N. and Fneish, F. and Ellenberger, D. and Flachenecker, P. and Paul, F. and Warnke, C. and Kleinschnitz, C. and Parciak, T. and Krefting, D. and Hellwig, K. and Haas, J. and Rommer, P.S. and Stahmann, A. and Zettl, U.K.
Neurology and Therapy 11
(1): 319–336.
March 2022
Network meta-analysis of food and drug administration-approved treatment options for adults with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder.
Wingerchuk, D.M. and Zhang, I. and Kielhorn, A. and Royston, M. and Levy, M. and Fujihara, K. and Nakashima, I. and Tanvir, I. and Paul, F. and Pittock, S.J.
Neurology and Therapy 11
(1): 123-135.
March 2022
This list was generated on Fri Apr 19 02:36:54 2024 CEST.